23^rd Biosimilar Medicines Conference

Join us for the 2027 Biosimilar Medicines Conference, 22&23 April 2027 at the Hilton Amsterdam Airport Schiphol Hotel!

We are delighted to invite you to the 23^rd Biosimilar Medicines Conference, #BIOS27, the place to meet for European (and global) stakeholders in the field of biosimilar medicines. For years, stakeholders, leading experts, and Key Opinion Leaders have come together and discussed how, within their respective remits, they can advance patient access to life-saving biological treatment – from industry, across institutions and regulatory agencies, to Healthcare Professionals and Patient Representatives – to name a few.

Biosimilar medicines are no longer perceived as “just” health and social enablers, but also a vital component of the strategic European biotech sector – they are key to EU pharmaceutical resilience.

Riding the wave of change in pharmaceutical policy and biosimilar regulatory science, BIOS27 will target both an emerging and well-known set of barriers and challenges across different markets, supply chains, and regions, enabling discussion on how we can best shape impactful policies which will ensure that biosimilar medicines deliver their full value – to patients and healthcare systems, in Europe and beyond.

We look forward to your insights and expertise, which will foster a rich exchange of perspectives and strengthen the contribution of biosimilar medicines in shaping the future of health systems and industrial policy. Register now and join us in April 2027!